Skip to content
November 6, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Sagoh
  • Page 30

Sagoh

Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy revolutionizing-antibacterial-discovery-the-5f-mdl-strategy
  • Chemotherapy and Targeted Therapy

Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy

Sagoh May 9, 2026 0
The global crisis of antimicrobial resistance (AMR) has long demanded a shift in how we identify new...
Read More Read more about Revolutionizing Antibacterial Discovery: The 5F-MDL Strategy
From Legacy to Liberation: How Genomic Research Rewrote One Family’s Breast Cancer Narrative from-legacy-to-liberation-how-genomic-research-rewrote-one-familys-breast-cancer-narrative
  • Patient Advocacy and Support

From Legacy to Liberation: How Genomic Research Rewrote One Family’s Breast Cancer Narrative

Sagoh August 10, 2025 0
Main Facts: The Generational Shift in Breast Cancer Survival For Carole Kruzick, the specter of breast cancer...
Read More Read more about From Legacy to Liberation: How Genomic Research Rewrote One Family’s Breast Cancer Narrative
A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict a-crisis-of-humanity-a-decade-of-broken-promises-on-healthcare-in-conflict
  • Breast Cancer Prevention and Lifestyle

A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict

Sagoh August 7, 2025 0
Ten years ago, the international community stood in the chambers of the United Nations Security Council and...
Read More Read more about A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict

Posts pagination

Previous 1 … 27 28 29 30

Recent Posts

  • Groundbreaking St. Jude Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Reshaping Future Care
  • Edwards Lifesciences Raises 2026 Outlook Following Robust Q3 Performance
  • The Age of the Autonomous Trial: Navigating the Human-Agent Frontier in Clinical Research
  • The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide
  • Decoding the Immune Frontier: New Insights into Genetic Diversity and Malaria Resistance

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

groundbreaking-st-jude-study-reveals-genetic-predisposition-as-major-driver-of-secondary-cancers-in-childhood-survivors-reshaping-future-care
  • Medical Research and Clinical Trials

Groundbreaking St. Jude Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Reshaping Future Care

Asep Darmawan November 5, 2026
edwards-lifesciences-raises-2026-outlook-following-robust-q3-performance
  • Treatment Innovations

Edwards Lifesciences Raises 2026 Outlook Following Robust Q3 Performance

Lina Hope November 5, 2026
the-age-of-the-autonomous-trial-navigating-the-human-agent-frontier-in-clinical-research
  • Treatment Innovations

The Age of the Autonomous Trial: Navigating the Human-Agent Frontier in Clinical Research

Nana Wu November 5, 2026
the-frontier-of-genetic-medicine-decoding-the-in-vivo-vs-ex-vivo-divide
  • Genomics and Precision Medicine

The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

Raul Delapena Setiawan November 5, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.